| Dokumendiregister | Ravimiamet |
| Viit | MSO-8/27-1 |
| Registreeritud | 02.01.2026 |
| Sünkroonitud | 05.01.2026 |
| Liik | Sissetulev kiri |
| Funktsioon | MSO Meditsiiniseadmed |
| Sari | MSO-8 Turujärelevalvega seotud nõustamine |
| Toimik | MSO-8/2026 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | Johnson & Johnson Consumer Services EAME Ltd |
| Saabumis/saatmisviis | Johnson & Johnson Consumer Services EAME Ltd |
| Vastutaja | Karl Kalev Türk (RA, Meditsiiniseadmete osakond) |
| Originaal | Ava uues aknas |
From: "Hamed, Sarah [VISEU Non-J&J]" <[email protected]>
Sent: Fri, 12 Sep 2025 04:17:20 +0000
To: "[email protected]" <[email protected]>
Subject: MD change notification in Estonia
Dear Sir or Madam
I am a Regulatory Affairs professional at J&J supporting the registration and compliance of medical devices in the EU.
I would like to understand the post-registration change requirements in Estonia for changes such as:
If any of these changes are subject to notification, could you please advise:
Thank you very much for your assistance in clarifying this matter. This will help ensure that we are fully aligned with Estonian regulatory requirements.
Best regards,
Sarah Hamed
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
| Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
|---|---|---|---|---|---|---|
| Küsimused | 02.01.2026 | 3 | MSO-8/27-2 | Väljaminev kiri | ra | Johnson & Johnson Consumer Services EAME Ltd |